Israel Active

Israel’s Biolojic Design is developing an AI platform to generate antibodies that have specific targets and biological effects. It instructs the immune system to precisely attack the causes of disease, such as the mechanism underlying autoimmune disease, cancer or diabetes.  

Tel Aviv University Professor Noam Shomron has developed an AI tool that interprets routine hospital blood tests to assess patients at danger levels in the case of blood infection.  The tool is shortly to be trialed at Tel Aviv’s Sourasky (Ichilov) Medical Center.

An Israeli-led team of scientists have developed a blood test that analyzes fragments of DNA to determine the impact of the immune system. The test is like a liquid biopsy and can detect cancer early in remote tissues, e.g., bone marrow, lymph nodes and other organs.

Scientists at Tel Aviv University have developed an experimental molecule that breaks down the protein TDP-43, a key cause of ALS (Lou Gehrig’s disease). TDP-43 causes motor neurons to degenerate. The new molecule enabled motor neuron activity to be restored and opens the door to an ALS cure.

Scientists at Israel’s Technion Institute have developed a method of removing copper ions that cause the toxic buildup of amyloid plaque in Alzheimer’s patients. Professor Galia Maayan and PhD student Anastasia Behar have patented the groundbreaking “chelation” (extraction) process.

Israel’s Genoox (see previously) has developed Franklin – a repository of genetic biopsy information relating to cancer mutations. Doctors in more than 1700 healthcare organizations in over 44 countries use Franklin to personalize cancer treatments to the patient’s genetic makeup.

United Hatzalah volunteer EMT Noemie was asleep after finishing a late shift in the pediatric ward of Sheba Hospital. She was suddenly alerted to go to the aid of a 92-year-old unconscious woman but had no time to get dressed. She saved her patient, performing CPR in her pajamas!

Israeli charity Save a Child’s Heart (SACH – see previously) is bringing its first group of Congolese children to the Jewish state for life-saving heart surgery at the Wolfson Medical Center in Holon.

Bar-Ilan University is creating a program to transform diabetes care. The Social Precision-medicine Health Equity Research Endeavour (SPHERE). is supported by a $20 million grant from the Russell Berrie Foundation and will identify genetic mutations that cause diabetes.

Comprehensive article describing the innovative device from Israel’s Votis (see previously) that can identify peripheral artery disease (PAD) in its very early stages.